21
Mar
2024
Megarounds Return, AZ Buys a Radiopharma Player, & Lonza’s California Dream
Please subscribe and tell your friends why it’s worthwhile. Quality journalism costs money. When you subscribe to Timmerman Report at $199 per year, you reward quality independent biotech reporting, and encourage more. Subscribe Now Sign in to your account.